Information
-
Trademark
-
85032922
-
Serial Number
85032922
-
Registration Number
3922441
-
International Classifications
-
Filing Date
May 07, 2010
14 years ago
-
Registration Date
February 22, 2011
13 years ago
-
Transaction Date
November 02, 2021
3 years ago
-
Status Date
September 24, 2021
3 years ago
-
Published for Opposition Date
December 07, 2010
14 years ago
-
Location Date
January 25, 2017
7 years ago
-
Status Code
710
-
Current Location
TMO LAW OFFICE 112
Employee Name
TOOLEY, DAVID E
-
Attorney Docket Number
6333-01500
Attorney Name
Dwayne K. Goetzel
Law Office Assigned Location Code
M30
-
Owners
Mark Drawing Code
4000
Mark Identification
OPEN TTG
Case File Statements
- D10000: "TTG"
- GS0011: Chemicals and biochemicals used in industry and science, chemicals and biochemicals for apheresis
- GS0051: Medicines, pharmaceutical, veterinary and sanitary preparations for the treatment, prophylaxis and diagnosis of diseases; (( pharmaceutical preparations in particular for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; chemical and biochemical preparations for medicinal purposes, chemical and biochemical preparations for sanitary purposes, chemical and biochemical preparations for medical and veterinary purposes, all the aforementioned for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; dietetic foods adapted for medical use and dietetic foods for medical and veterinary purposes; food supplements for medical purposes; disinfectants for sanitary purposes; preparations for destroying vermin; chemical and biochemical preparations for use in medical science for use in or on human and/or animal bodies for the treatment, prophylaxis and diagnosis of autoimmune disorders, gluten-sensitive autoimmune disorders, coeliac disease, dermatitis herpetiformis, Duhring's disease, gluten-sensitive ataxia, food incompatibilities, intestinal disorders, irritable bowel syndrome, fibrosis, scar formation, hypertrophic scars, scleroderma, diabetic nephropathies, liver fibrosis, cirrhosis, lung fibrosis, arteriosclerosis, cancer, thrombolysis, acne, skin ageing, psoriasis, neurodegenerative disorders, Alzheimer's disease, Huntington's disease, Parkinson's disease, cataracts, affliction by micro-organisms, infections or candidosis; diagnostic preparations for medical purposes; radiological contrast agents for medical purposes, germicidal detergents for medical purposes, pharmaceutical preparations for apheresis ))
Case File Event Statements
-
9/24/2021 - 3 years ago
31 - CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Type: CAEX
-
2/22/2020 - 4 years ago
30 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Type: REM2
-
1/25/2017 - 7 years ago
29 - NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Type: NAS8
-
1/25/2017 - 7 years ago
28 - SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Type: NA15
-
1/25/2017 - 7 years ago
27 - REGISTERED - SEC. 15 ACKNOWLEDGED
Type: 15AK
-
1/25/2017 - 7 years ago
26 - REGISTERED - SEC. 8 (6-YR) ACCEPTED
Type: 8.OK
-
1/25/2017 - 7 years ago
25 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Type: APRE
-
1/12/2017 - 7 years ago
24 - TEAS SECTION 15 RECEIVED
Type: E15R
-
1/12/2017 - 7 years ago
23 - TEAS SECTION 8 RECEIVED
Type: ES8R
-
2/22/2011 - 13 years ago
22 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
12/7/2010 - 14 years ago
21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
12/7/2010 - 14 years ago
20 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
11/2/2010 - 14 years ago
19 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
11/2/2010 - 14 years ago
18 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
11/2/2010 - 14 years ago
17 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
11/2/2010 - 14 years ago
16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
11/2/2010 - 14 years ago
15 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
11/2/2010 - 14 years ago
14 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
11/1/2010 - 14 years ago
13 - NOTIFICATION OF PRIORITY ACTION E-MAILED
Type: GPRN
-
11/1/2010 - 14 years ago
12 - PRIORITY ACTION E-MAILED
Type: GPRA
-
11/1/2010 - 14 years ago
11 - PRIORITY ACTION WRITTEN
Type: CPRA
-
10/1/2010 - 14 years ago
10 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
10/1/2010 - 14 years ago
9 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
10/1/2010 - 14 years ago
8 - ASSIGNED TO LIE
Type: ALIE
-
9/30/2010 - 14 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
8/25/2010 - 14 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
8/25/2010 - 14 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
8/25/2010 - 14 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
8/19/2010 - 14 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
5/14/2010 - 14 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
5/11/2010 - 14 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP